ActiveSC828508Private limited companyGlasgow

RAER THERAPEUTICS LTD

Significant control: Nathan Mcnally (25–50%), Laura Anne Towart (25–50%) and 1 more

Companies HouseCompanies House

From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms

Watch this company

Get an email when Companies House records a change for Raer Therapeutics Ltd: status, filings, accounts, officers or owners. Free.

Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy

Coming soon · product and service lists

What does Raer Therapeutics Ltd sell?

Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.

One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01

Summary

Generated from filed data · no estimates

RAER THERAPEUTICS LTD is an active private limited company (company number SC828508) incorporated on 11 November 2024, registered in Glasgow. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest dormant accounts cover the period ending 30 November 2025, showing net assets of £3 and cash of £3.

Peer position · net assets

By net assets it sits in the lower half of 2,418 comparable companies in the UK (median £1,000, upper quartile £92k).

02

Ownership and control

3 active · 1 other
  • Mr Nathan Mcnally
    Individual · since 11 November 2024
    • owns 25–50% of shares
    • holds 25–50% of voting rights
    • can appoint or remove directors
  • Ms Laura Anne Towart
    Individual · since 11 November 2024
    • owns 25–50% of shares
    • holds 25–50% of voting rights
    • can appoint or remove directors
  • Prof Ross Leigh Cagan
    Individual · since 11 November 2024
    • owns 25–50% of shares
    • holds 25–50% of voting rights
    • can appoint or remove directors
  • Mr James Hadwin
    Individual · since 1 March 2025 · ceased 30 June 2025
    • owns 25–50% of shares
    • holds 25–50% of voting rights

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.

03

Key dates

Incorporated
11 November 20241 yr ago
Next accounts due
30 August 2027in 310 days
Confirmation statement due
25 November 2026in 32 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

04

Activity

SIC 72110
Research and experimental development on biotechnology
Accounts type
Dormant
Size band
MicroCompanies Act thresholds
05

Financials

1 period on record · latest ending 30 November 2025
Net assets
£3
1 period on record
Cash at bank
£3
1 period on record
Turnover
Not reported
Employees
Not reported
Filed accounts by period, newest first
Period endNet assetsCashDebtorsCreditors <1yTurnoverProfitEmployees
30 November 2025£3£3—————

Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.

06

Filing and accounts signals

Facts from the register · no rating
  • Net assets above zeroNet assets £3 at 30 November 2025
  • Incorporated less than two years agoIncorporated 11 November 2024; no accounts due yet

Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.

07

Timeline

Newest first
  1. Next accounts duein 310 days
  2. Confirmation statement duein 32 days
  3. Accounts period endNet assets £3 · dormant accounts
  4. Incorporated
08

Similar companies in Glasgow

Same activity (research and experimental development on biotechnology), closest in incorporation date
09

Reminders for RAER THERAPEUTICS LTD

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.

Source: Companies House register, snapshot 2026-08-31; accounts from the Companies House accounts data product. Open Government Licence v3.0. View on Companies House. Methodology · About · Markdown.